Video

Patient Selection for Atopic Dermatitis Therapies

Author(s):

Raj Chovatiya, MD, PhD,Elizabeth Swanson, MD

Elizabeth A. Swanson, MD, provide insight on identifying the appropriate patients for various therapeutic regimens in atopic dermatitis.

Related Videos
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Linda Stein Gold, MD: Discussing New Phase 3b Data on Lebrikizumab for Atopic Dermatitis
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Related Content
Study Highlights Interim Results on Abrocitinib for Adolescents, Adults with Atopic Dermatitis
December 19th 2024

Study Highlights Interim Results on Abrocitinib for Adolescents, Adults with Atopic Dermatitis

Tim Smith
Advances in Pediatric Eczema Highlight 2022
December 21st 2022

Advances in Pediatric Eczema Highlight 2022

Kevin Kunzmann
Coco Dekkers, PhD candidate I Credit: LinkedIn
December 18th 2024

Tralokinumab Effectively Treats Moderate-to-Severe Atopic Dermatitis: Real-World Data

Chelsie Derman
How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care
July 12th 2022

How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care

Armand Butera
Christopher G. Youn, MD Candidate I Credit: Stanford Biosciences
December 18th 2024

Parents of Children with Atopic Dermatitis Often Sleep Less Than 7 Hours

Chelsie Derman
FDA Receives sNDA for Roflumilast Cream Treatment of Children with Atopic Dermatitis
December 16th 2024

FDA Receives sNDA for Roflumilast Cream Treatment of Children with Atopic Dermatitis

Tim Smith
© 2024 MJH Life Sciences

All rights reserved.